Physician

Paul A Slota, M.D.

According to 2025 Medicare claims, Paul Slota, M.D. (NPI: 1104877257) practices cardiology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is CAROLINA HEART SPECIALISTS LLC (NPI: 1881802841; TIN: 260154591) and primary practice location at 29732-3047.

Slota's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 928 traditional Medicare patients, billed 6,855 HCPCS/CPT codes, and received $573,564 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 6,897 prescription claims across 869 beneficiaries totaling $866,424 in drug costs, led by Eliquis (Apixaban). DME data shows 198 claims. Open Payments data shows 45 records totaling $976. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $409,512 to $866,424. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,862 to $7,651.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	978	7,911	$629,219
2016	1,061	9,196	$683,557
2017	1,132	8,918	$662,451
2018	1,316	9,768	$680,059
2019	1,310	10,304	$807,332
2020	1,215	9,222	$736,572
2021	1,065	8,115	$680,676
2022	972	6,916	$602,242
2023	973	6,493	$554,202
2024	928	6,855	$573,564

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	618	9,206	$409,512
2016	678	9,196	$446,924
2017	726	8,021	$461,162
2018	790	6,918	$432,640
2019	862	6,651	$530,147
2020	888	6,727	$600,818
2021	894	6,468	$655,991
2022	808	6,336	$661,538
2023	819	6,753	$764,087
2024	869	6,897	$866,424

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$445
2016	N/R	23	$1,398
2017	N/R	22	$284
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$909
2021	N/R	17	$995
2022	N/R	40	$820
2023	12	112	$3,697
2024	29	198	$6,296

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	307	307	$324
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	645	673	$124
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	306	612	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	541	831	$89
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	577	958	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	334	20,305	$385,823
Camzyos	Mavacamten	18	515	$139,499
Xarelto	Rivaroxaban	89	4,935	$88,672
Entresto	Sacubitril/Valsartan	61	3,780	$79,332
Repatha Sureclick	Evolocumab	19	980	$18,862

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	36	$1,150
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	11	$984
A7030	Full face mask used with positive airway pressure device, each	N	N/R	12	$965
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	17	$816
A7031	Face mask interface, replacement for full face mask, each	N	N/R	11	$738

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$976	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul A. Slota, M.D.?

Tedicare shows public-source Medicare data for Paul A. Slota, M.D. (NPI 1104877257), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul A. Slota, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul A. Slota, M.D.?

Paul A. Slota, M.D. is linked to CAROLINA HEART SPECIALISTS LLC (billing NPI 1881802841) in the available physician profile data.

Does Paul A. Slota, M.D. have Open Payments data?

Paul A. Slota, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.